Results 241 to 250 of about 65,396 (285)

Acute fulminant necrotising lymphocytic myocarditis in a patient with mixed connective tissue disease: a rapid clinical response to immunosuppression.

, 2014
Sarah Fairley, Brian Herron, Carol M. Wilson, Michael J. Roberts   +3 more
openalex   +1 more source

Tuberculous Meningitis: A Coexisting Infection in a Case of Mixed Connective Tissue Disease

Saima Ilyas, Auzib Siddique, Aneela Asghar, K John, M Sadiq, T George, K Gunasekaran, N Francis, 1 Rajadurai, E, Y Tanaka, M Kuwana, T Fujii, H Kameda, Y Muro, K Fujio, F Dernie, A Prats-Uribe, Man Wy, A Delmestri, Prieto-3. Alhambra D, K Chevalier, B Thoreau, M Michel, B Godeau, C Agard, 4 Papo, T, M Azzam, A Awad, A Abugharbyeh, B Kahaleh, A Agrawal, A Kohat, C Sahu, C Kansal, Fatima, De Oliveira, I Rocha-Filho, Pas, C Palacios, P Saleeb, W Lin, P Chen, L Hamijoyo, E Sahiratmadja, N Ghassani, G Darmawan, E Susandi, R Van Crevel   +49 more
openalex   +2 more sources

Mixed connective tissue disease

, 2012
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mixed connective tissue disease

Clinics in Dermatology, 1985
Abstract Mixed connective tissue disease (MCTD) was first described by Gordon Sharp, 1 in 1972, as a distinct connective tissue disorder characterized by overlapping features of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and dermato/polymyositis (DP/PM).
D T, Schreiner, J L, Jorizzo
openaire   +3 more sources

Mixed Connective Tissue Disease

Current Opinion in Rheumatology, 2000
A defining feature of mixed connective tissue disease (MCTD) is the presence of antibodies against the U1-ribonucleoprotein (RNP) complex, but other autoantibodies in MCTD have recently been described. Research has also further elucidated the immune responses directed against U1-RNP in humans and in murine models of disease.
R W, Hoffman, E L, Greidinger
openaire   +2 more sources

Mixed Connective-Tissue Disease

New England Journal of Medicine, 1977
Coping with chronic illness has become a personal experience for me. For the past 13 years, I have gone through various stages of coping with mixed connective tissue disease (MCTD), a rare collagen-vascular disease of unknown origin that resembles scleroderma, lupus erythematosus, and polymyositis.
openaire   +4 more sources

Mixed connective tissue disease

Best Practice & Research Clinical Rheumatology, 2016
The concept of mixed connective tissue disease (MCTD) as a separate connective tissue disease (CTD) has persisted for more than four decades. High titers of antibodies targeting the U1 small nuclear ribonucleoprotein particle (U1 snRNP) in peripheral blood are a sine qua non for the diagnosis of MCTD, in addition to distinct clinical features including
Ragnar, Gunnarsson, Siri Opsahl, Hetlevik, Vibke, Lilleby, Øyvind, Molberg   +3 more
openaire   +2 more sources

Pediatric Mixed Connective Tissue Disease

Current Rheumatology Reports, 2016
Pediatric-onset mixed connective tissue disease is among the rare disease entities in pediatric rheumatology and includes features of arthritis, polymyositis/dermatomyositis, systemic lupus erythematosus, and systemic sclerosis. Accurate recognition and diagnosis of the disease is paramount to prevent long-term morbidity.
Roberta A, Berard, Ronald M, Laxer
openaire   +2 more sources